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Abstract
There is an emerging evidence base that global trade is linked with the rise of chronic disease in many low and
middle-income countries (LMICs). This linkage is associated, in part, with the global diffusion of unhealthy lifestyles
and health damaging products posing a particular challenge to countries still facing high burdens of
communicable disease. We developed a generic framework which depicts the determinants and pathways
connecting global trade with chronic disease. We then applied this framework to three key risk factors for chronic
disease: unhealthy diets, alcohol, and tobacco. This led to specific ‘product pathways’, which can be further refined
and used by health policy-makers to engage with their country’s trade policy-makers around health impacts of
ongoing trade treaty negotiations, and by researchers to continue refining an evidence base on how global trade
is affecting patterns of chronic disease. The prevention and treatment of chronic diseases is now rising on global
policy agendas, highlighted by the UN Summit on Noncommunicable Diseases (September 2011). Briefs and
declarations leading up to this Summit reference the role of globalization and trade in the spread of risk factors for
these diseases, but emphasis is placed on interventions to change health behaviours and on voluntary corporate
responsibility. The findings summarized in this article imply the need for a more concerted approach to regulate
trade-related risk factors and thus more engagement between health and trade policy sectors within and between
nations. An explicit recognition of the role of trade policies in the spread of noncommunicable disease risk factors
should be a minimum outcome of the September 2011 Summit, with a commitment to ensure that future trade
treaties do not increase such risks.
Background
The nature and magnitude of the burden of chronic dis-
ease in low and middle-income countries (LMICs) is
now well understood, as are its impacts on health sys-
tems and national economies [1-5]. What is less clear is
how we should address chronic disease in LMICs,
although doing so will require actions at both local and
global levels [6]. At the global level, international trade,
despite bringing potential health benefits through eco-
nomic growth (a point we return to) is one of the major
driving factors of a growing chronic disease burden.
Trade’s effects on chronic disease risk occur progres-
sively along multiple pathways. It is the intent of this
article to explicate those pathways, of particular impor-
tance given the high-level international attention now
being directed to the global chronic disease burden.
Trade is not a new phenomenon: human societies
have long histories of trade with each other and one
might even describe barter and exchange as inherently
human social qualities [7]. What is new is the volume of
trade in goods and services, which has reached unprece-
dented levels over the past century; and the global scale
at which trade now occurs. Also, the pattern of trade
has morphed into an unequal playing field, where inter-
national trade rules tend to benefit disproportionately
high-income countries [8-11]. The rise in global produc-
tion chains, liberalization of global financial flows and
stark inequalities in countries’ political and bargaining
power are at the heart of many of the contentions con-
cerning contemporary global trade.
Health concerns associated with trade have been a fea-
ture of national and global policy debate since the estab-
lishment of the World Trade Organization (WTO) in
1995 and its extensive suite of trade treaties aimed at
progressively liberalizing the cross border flow of goods,
services and finance. Such concerns are far from new.
Disease has long followed trade routes, from infectious
pandemics of past eras to SARS in more recent times.
The link between trade and infectious disease has been
well documented [12-14]; and there is now an emerging
evidence base that global trade is also linked with the
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rise of chronic disease in many LMICs. This linkage is
associated, in part, with the global diffusion of unhealthy
lifestyles and health damaging products [15], posing a
particular challenge to countries still facing high bur-
dens of communicable disease.
The existing literature on trade and chronic disease
has tended to focus on certain health problems, such as
diabetes and overnutrition [16,17]. Lacking is an under-
standing of how such trade affects chronic disease more
generally and through multiple pathways. To address
this knowledge gap, we developed a generic framework
which depicts the determinants and pathways connect-
ing global trade with chronic disease. We then applied
this framework to three key risk factors for chronic dis-
ease: unhealthy diets, alcohol, and tobacco. This led to
specific ‘product pathways’, which we propose can be
further refined and used by health policy-makers to
engage with their country’s trade policy-makers around
health impacts of ongoing trade treaty negotiations, and
by researchers to continue refining an evidence base on
how global trade is affecting patterns of chronic disease.
We focused our evidence gathering primarily on Latin
America, sub Saharan Africa, and Asia, where the
impact of international trade agreements in the global
flow of these products has been subject of greatest
health comment and concern.
Trade, chronicity and chronic disease
’Chronicity’ has been proposed as an appropriate lens to
address the complexities associated with rising burden
of chronic diseases [18] and has been identified as the
theme for this special issue. The concept of chronicity
has conventionally been applied to understanding the
nature of care of chronic diseases [19]. However, the
term is also applicable to the causes of chronic diseases.
Specifically, we view chronicity in two ways: first, as the
post-1980s reconfiguration of globalization (particularly
economic aspects of trade and investment liberalization
following what has been characterized as neo-liberal
economic principles)[20], which has led to the interna-
tional transmission of risk factors for non-communic-
able disease; and second, as the durability of this model
even in the face of multiple, and more recently global,
financial crises. Trade-related global market integration
has essentially made such disease risk factors ‘commu-
nicable’ (with food, tobacco and alcohol consumption
serving as ‘vectors’), blurring the conventional distinc-
tion between communicable and chronic diseases.
Policy space, policy capacity, trade treaty rules, and risks of
chronic disease
’Policy space’ is the term frequently used to describe
“the freedom, scope, and mechanisms that governments
have to choose, design and implement public policies to
fulfill their aims” [[21], p.7]. Policy capacity refers to the
fiscal ability of states to enact those policies or regula-
tions, which depends upon their ability to capture suffi-
cient revenue through taxation for this purpose. Both
space and capacity can be affected by trade treaties. One
concern with trade treaties is their ‘behind the border’
shrinking of policy space by prohibiting a range of
‘trade-related’ domestic regulatory options that could be
used to promote healthy habits or, conversely, to restrict
unhealthy ones. Although governments still retain sub-
stantial policy flexibilities within existing trade treaties,
these flexibilities continue to be eroded through ongoing
treaty negotiations, notably those associated with bilat-
eral or regional trade treaties. Such treaties are exempt
from the most favoured nation rule of WTO agreements
under which trade terms between any WTO member
nations must be given to all member nations. The
exemption for bilateral and regional treaties allows for
more favourable terms (usually with respect to market
access) for countries that participate in them. Regional
treaties hold the prospect for more equitable forms of
trade amongst countries of similar size or development
level [22]. However, such treaties, especially those with
wealthier countries or trading blocs, such as the USA
and EU, are often ‘WTO+.’ They include trade, services
and finance liberalization commitments, protection of
intellectual property rights and agreements on govern-
ment procurement that go beyond those present in
existing WTO trade treaties, and which can limit policy
space to a much greater extent than WTO trade rules
[22-24].
The primary purpose of all trade treaties is to reduce
barriers to cross-border trade. One of the key principles
underlying this purpose is non-discrimination: foreign
goods or committed services covered by a trade treaty
must be treated the same as the identical or ‘like’
domestic good or service. Another principle is national
treatment. Internal tax and regulatory measures must be
applied equally to imported and domestic goods or
committed (scheduled) services in order to avoid trade
disputes. To protect population health found to be in
violation of trade agreements (the so-called health
defense), governments have to prove that these policies
are ‘necessary.’ Past and ongoing disputes over regula-
tions governing tobacco imports and additives, and alco-
hol products, highlight the stringency with which this
requirement is pursued [25]. Further limitations on the
health defense include requirements that domestic regu-
lations that could discriminate against foreign imports,
even if treated no differently than national goods, must
be based upon international standards or scientific risk
assessments [7]. These trade principles constrain policy
space. Policy capacity, in turn, refers to the resources
states have to monitor or enforce regulations that they
are able to promulgate. The issue of capacity is of
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considerable importance to LMICs, many of which have
excellent laws ‘on the books’ but lack effective enforce-
ment measures. The policy capacity trade issue is that
liberalization requires progressive reductions in tariffs
(border taxes). Developing countries rely more heavily
upon tariffs for their tax revenue than do developed
nations. Although developing countries are granted
more latitude in retaining higher tariff levels, they are
under considerable trade negotiation pressure to lock in
and reduce their tariffs, in both multilateral WTO nego-
tiations and notably in bilateral and regional trade trea-
ties. In theory, developing country governments should
be able to shift their tax bases from tariffs to sales or
income taxes, assuming their economies grow with
increased liberalization. In reality, many developing, and
most low-income, countries subject to tariff reductions
as conditions for loans from the international financial
institutions (the World Bank and IMF) have been
unable to do so [26,27], partly as a result of inadequate
institutions to implement alternate tax regimes [28]. For
a majority of these countries there has been a net
decline in overall public revenues [29] - a loss in policy
capacity - with implications for spending in health, edu-
cation or public regulations that can affect primary and
secondary prevention of chronic disease.
Generic framework
Figure 1 provides a generic framework of the linkages
between chronic disease and international trade. Trade
can be broadly segmented into two categories: treaty,
which includes bilateral, regional or multilateral under
the World Trade Organization (WTO) and non-treaty,
which includes both legal (but non-treaty) and illicit
trade. Trade treaties can affect trade in goods in two
main ways: increased trade in raw or finished products
(depicted with solid arrow lines) and increased foreign
investment in domestic production, manufacturing, and
distribution (depicted with dotted arrow lines).
Increased imports and domestic production result in
increased domestic availability of a particular product.
Greater quantity and availability, in turn, increases price
competition (lower prices) and marketing and (gener-
ally) promotion of the product, both of which lead to
increased product consumption. Increased consumption
can have positive or negative consequences on chronic
diseases depending on whether it is a health-promoting
(e.g. nutritious food) or health-damaging (e.g. highly
processed food) product. Increased foreign investment
in a particular product can also lead to economic
growth which, if adequately taxed, can contribute to rev-
enues for health and other health-promoting social pro-
grams. However, if this product has harmful effects (e.g.
tobacco) increased consumption is more likely to lead
to poorer health outcomes, burdening health systems
and offsetting any economic gains. Moreover, increased
imports and foreign investment can displace domestic
producers and manufacturers, which can reduce local
revenues, food security (if local food crops are displaced)
and increase dependency on foreign companies, making
it more difficult to introduce regulations constraining
their market growth or raising corporate taxes. Non-
treaty trade in products has similar effects apart from
legally binding constraints on a country’s tariffs or
domestic policies. Illicit trade is difficult to document
for most products and therefore we do not discuss it in
this paper.
Specific pathway products
Food trade and chronic disease
The pathways linking trade and foreign direct invest-
ment from food to chronic disease are described below.
We identify three general pathways which relate to the
changes in the food system: growth of transnational
food corporations; liberalization of international food
trade and investment and global food advertising and
promotion. While international trade is a key driver for
rising chronic disease linked to changing food consump-
tion patterns, there are other factors, such as urbaniza-
tion, which are also important [30,31], but a discussion
of these factors are beyond the scope of this paper.
Urbanization, however, can also be indirectly linked to
international trade, becoming part of the broader social
system that we discuss briefly [32].
Growth of transnational food corporations (TFCs)
Food production, distribution, and retailing have been
consolidated into a small number of transnational food
corporations (TFCs). Food retailers in particular have
undergone an intense and rapid transformation; changes
that occurred in regions such as Latin America between
1990 and 2000 took place in the US over a period of 50
years [33]. In 2003, the top 30 food retailers controlled
almost 30% of the market in Latin America and 19% in
Asia and Oceania [32]. Reardon and his colleagues have
labeled the retail transformation beginning in the early
1990s as a ‘take-off’ period [34], launching a ‘supermar-
ket revolution’ and the rapid spread of fast food chains.
Supermarkets are rapidly increasing (they are now the
dominant food retailer in Latin America), and the trans-
formation can be characterized in two ways [33]. First,
rapid consolidation occurred where a small number of
supermarket chains usurped domestic chains. The sec-
ond way in which this transformation is occurring is
through rapid multinationalization. For example, Wal-
Mart has emerged as the largest chain since it began to
sell food 10 years ago to the extent that Mexicans spend
3 out of every 10 pesos on food at Wal-Mart [35].
The growth of supermarkets during the 1990s can be
attributed to demand side factors, notably urbanization,
Labonté et al. Globalization and Health 2011, 7:21
http://www.globalizationandhealth.com/content/7/1/21
Page 3 of 15
the entry of women into the workforce, and economic
growth [33]. The supply side was driven by trade liberal-
ization and foreign direct investment (FDI). Conditions
for FDI were facilitated through the easing on FDI regu-
lations as part of structural adjustment programs and
free trade agreements. FDI has played a critical role in
the diet transition as it has especially targeted highly
processed foods [36]. There is a close correspondence
between a rise in FDI and increased investments in pro-
cessed foods. In Latin America, between 1988 and 1997,
FDI in food industries grew from US$ 222 million to US
$ 3.3 billion [37]. Supermarkets have focused on highly
processed foods because of their long shelf lives and for
the potential economies of scale [38]. There is a strong
plausible link between the rise of supermarkets and diet-
ary changes, although there is little empirical evidence
due to a simple lack of studies on this topic [32].
Liberalization of international food trade and invest-
ment Liberalization of trade - eliminating quotas, redu-
cing tariffs, and privatizing state trade agencies - was
adopted by many LMICs either voluntarily or as a
condition of structural adjustment loans from the inter-
national financial institutions initiated in the 1980s, with
a quickening pace during the 1990s as many countries
entered into global, regional, and bilateral trade agree-
ments [32]. Food was first represented in multilateral
trade treaties with the formation of the WTO in 1995
and adoption of the Agreement on Agriculture (AoA).
Before this time, agricultural trade existed largely out-
side of formal trade treaties, and developing countries
did not have to reciprocate in granting greater market
access to developed country exports. With the WTO’s
trade rules and dispute settlement procedures, develop-
ing countries are under increasing obligation and
ongoing negotiation pressures to lower tariffs, export
subsidies and domestic agriculture support (AoA), as
well as to open themselves to FDI in food-related sec-
tors they may have committed under the General Agree-
ment on Trade in Services (GATS). Alongside a growing
number of bilateral and regional treaties, such as the
North American Free Trade Agreement (NAFTA), the
Central American Free Trade Agreement (CAFTA), and






























Figure 1 A generic framework of the linkages between chronic disease and international trade.
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the Southern Common Market (MERCOSUR), regula-
tion of international food trade and investment is
increasingly governed by trade treaty rules. A specific
example of trade treaty effects on health-related food
policies includes the long-standing dispute between the
European Union and several countries over the EU ban
on hormone-treated beef (the ban violates requirements
for scientific risk assessments under the WTO Agree-
ment on Sanitary and Phytosanitary Standards) [39].
Another example involves the threat of a trade dispute
involving the Gerber company and Guatemala over the
latter’s effort to abide by the infant formula code (Inter-
national Code of Marketing of Breast-milk Substitutes)
by banning the ‘pudgy baby’ picture on Gerber infant
formulas (which the company argued was an infringe-
ment of its intellectual property rights) [39].
At the start of the new millennium, food represented
11% of international trade (likely more today), with the
rise of processed food occurring more quickly than pri-
mary agricultural products [40]. While international
trade of food and food-products has increased, so have
the level of subsidies provided to agricultural producers
in high-income countries (notably the USA, the EU and
Japan) with much of their produce (particularly Ameri-
can and European) going to export markets. This has
led some trade policy analysts to argue that the high
level of subsides can be viewed as dumping [41], defined
in trade terms as goods entering a foreign market at less
than ‘normal’ prices. These subsidies are due to be
reduced under the terms of the AoA (which gave WTO
member nations a 10 year moratorium from trade dis-
putes related to agriculture, which expired on December
31, 2004); although both the US and the EU have been
altering slightly the terms of their subsidies to allow
them to still qualify under the AoA’s complex set of
‘boxes’ permitting some, but disallowing other, supports
to domestic producers. Much prevailing criticism of
subsidies is that they damage the value of food exports
from developing countries by suppressing world prices.
From a public health vantage, eliminating production
subsidies on unhealthy food products (such as fats and
sugars) is likely to do more health good than harm for
all countries. But their elimination on healthier and
essential food products could do more harm than good
to many low-income countries which have become net-
food importers - as a result of population growth, loss
of arable land and years of advice to shift from food
products for domestic consumption to non-food cash
crops (cotton, coffee, tobacco) for export [29,42].
FDI in food-related production, processing and retail-
ing, enhanced by reducing investment barriers, has
increased the presence of TFCs in most developing
countries. This presence can increase food availability
through reduction in retail prices following the removal
of import barriers on food, depending on the dynamics
of international and domestic prices. Food retail prices
can also be lowered by the reduction of investment bar-
riers since TFCs often purchase agricultural products at
lower cost and promote economies of scale, but they
also benefit from the lower agricultural cost of their
own products. Hawkes and Thow demonstrate these
effects in their analysis of the Central America - Domin-
ican Republic - Free Trade Agreement [43], which the
authors argue will likely lead to greater consumption of
highly processed food, meat, and other non-traditional
foods in Central America.
Liberalization of trade in food products can increase
availability and lower retail prices [43,44]. Food avail-
ability increases due to reductions of import barriers on
foods; although total food availability depends on
whether or not there is a concomitant decline in domes-
tic production, or the amount of domestic production
that converts to export crops. Impacts on domestic pro-
duction raise concerns about short- and longer-term
food security. A recent study by the United Nations
Food and Agriculture Organization (FAO) examined
trade liberalization and food security in fifteen small and
large developing countries (Chile, Guatemala, Guyana,
Peru, Cameroon, Ghana, Kenya, Malawi, Morocco,
Nigeria, Senegal, Tanzania, Uganda, China, and India).
Their key finding was that “trade reform can be dama-
ging to food security in the short to medium term if it
is introduced without a policy package designed to offset
the negative effects of liberalization” [[42], p. 75). The
study went on to caution that trade reforms generally
benefit farmers producing exports crops, but have nega-
tive impacts on farmers producing import-competing
food stuffs, especially those that are highly subsidized by
exporting countries. For low-income countries whose
economies are still heavily dependent on agriculture,
raising agricultural productivity and creating non-agri-
cultural employment should precede trade reforms such
as tariffs reductions on crops grown by low-income
households. Production subsidies in developing coun-
tries, the report concluded, should also be permitted if
these are directed principally to subsistence or resource-
poor farmers.
Trade liberalization can also affect food security at the
household level. Studies by the International Food Policy
Research Institute (IFPRI) in the 1980s examined the
nutritional impact of a series of cash cropping schemes
in ten developing countries. The findings suggested that
cash cropping generally results in higher incomes and
spending on food, but has a relatively small impact on
energy intake, and, in most cases, little or no impact on
childhood malnutrition [45]. Several projects actually
had negative impacts on nutrition. Where improvements
did occur, most were attributed to the control of income
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within the household. Female-controlled incomes were
related to higher levels of caloric intakes among chil-
dren, as women are more likely than men to allocate
resources towards food.
Hawkes and her colleagues reviewed the available evi-
dence on the links between international trade and diet-
ary patterns [32]. They found supporting evidence,
notably from India and the Pacific Islands, that the
increase in international trade has shifted dietary pat-
terns from local, ‘healthy’ diets to the consumption of
fattier diets. One study from Colombia found that the
proportion of calories consumed from imported foods
has increased over time, but the extent to its contribu-
tion to increased energy availability is not clear. There
was also some limited evidence to support some
authors’ claims that changing diets has influenced trade
and that international trade is simply responding to new
demands.
Food exports are another core component of the liber-
alization of the international food trade [46]. Support for
export industries is promoted by the International Trade
Centre, which is a cooperative agency composed of the
United Nations Conference on Trade and Development
and the WTO. The focus of these policies has been
especially on the exportation of ‘cash crops’. Increasing
cash crops decreases land available for domestic crops,
requires fewer farmers for domestic production, and
reduces the production of traditional food crops for
local diets. This has led to a decline in consumption of
traditional food crops and often a decline in the ‘pres-
tige’ of traditional foods. These effects are particularly
harmful in areas where undernutrition rates are still
high and influence levels of food security for poor and
marginalized groups. More recently, several high-income
countries have been entering into long-term land lease
arrangements with poorer, indebted countries to grow
food specifically to meet the needs of citizens of the
high-income nations. This new development has
increased concern over future food security in poorer
countries [47-49].
Global food advertising and promotion Advertising
and promotion marks the third pathway through which
trade is affecting food systems and chronic disease. In
order to dominate in competitive food retailing markets,
corporations employ aggressive marketing techniques.
Spending on food advertising is now higher than it is
for tobacco [35]. In 2004, Coca Cola spent US$ 2.2 bil-
lion and PepsiCo spent US$ 1.7 billion on marketing of
soft drinks [37]. The global food advertising has been
steadily growing and the advertisement market is con-
trolled by a few communications networks [32]. Pro-
cessed food, especially targeted to children, has been the
main focus of promotion and advertising [32]. FDI has
also played a major role in marketing products [25,35].
Global food advertising has especially targeted develop-
ing countries in its search for new markets, with a focus
on highly processed foods. In 2002, almost 60% of food
advertisements in Brazil were for foods high in fats and
sweeteners [50].
Advertising and product marketing has contributed to
changing cultural expectations of food [37] and the “sys-
tematic molding of taste by giant corporations” [[35], p.
1559]. Marketing has been especially targeted to youth.
During the late 1990s, soft-drink companies targeted
school children by selling products in attractive combi-
nation packages in schools in Mexico and Colombia,
which led to a 50% increase in soft drink sales among
children [32]. Evidence from industrialized and develop-
ing countries found that children engage with food
advertising and that there is clear link between advertis-
ing to children and the consumption of these products
[51,52].
Social change Given that the diet transition advances
with rising incomes, urbanization, and changes in the
labour market, it can be expected that trade liberaliza-
tion- when it leads to economic growth, increasing
employment, and urbanization - will also influence the
diet transition as changes in lifestyles and new food
demands arise [32]. However, since liberalization does
not always or necessarily lead to economic growth,
diets may not be markedly influenced. When trade-
related economic growth does occur, economic
inequalities that generally accompany such growth can
lead to the poorest groups with limited access to food
and the abilityto meet their basic nutritional require-
ments. This can generate patterns of overnutrition
and undernutrition in the same country, particularly
in LMICs. There are only a few studies that have
demonstrated links between trade liberalization,
employment conditions, and nutrition. Better jobs and
higher incomes can lead to changes in food prefer-
ences and capacity to buy new foods. However, time
constraints and more women in the labour force can
lead to increased consumption of energy-dense, time
saving foods. Job insecurities and limited access to
family and welfare benefits can also restrict healthy
food choices. In sum, although there are links between
economic growth, urbanization, and changing labour
markets, the nature of these links are not clear and
likely depend on the particular context.
Tobacco trade and health
Trade liberalization in tobacco products is a concern for
its potential to offset declining use in developed coun-
tries by penetrating new markets in developing nations.
Trade can increase the disease consequences of tobacco
consumption through two main pathways: trade and
investment liberalization; and the impact of trade rules
on government policy space.
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Liberalization of international tobacco trade and
investment Trade liberalization has led to increased
tobacco consumption in LMICs [53] through a combi-
nation of tariffs reduction, liberalization in FDI and
minimal national tobacco control measures. This combi-
nation of factors increases competition in domestic mar-
kets, contributes to a reduction in the prices of tobacco
products and an increase in advertising and promotion
expenditures; all of which lead to increases in tobacco
consumption. As one example of this, Honjo and Kawa-
chifound that market liberalization lead to a one year
increase in US tobacco products in Japan from 16% in
1986 to 32% in 1987 and a corresponding stall in the
decline of tobacco consumption among adults and
increase in the level of consumption among adolescent
girls [54]. When South Korea opened its domestic mar-
ket to US tobacco company cigarette imports there was
an 11% increase in smoking among males and an 8%
increase among females in just one year [55]. Similar
interactions have taken place in bilateral trade agree-
ments, including an agreement between the US and
China in which China was required to cut tariffs on
imported cigarettes. Consumption patterns corre-
sponded with the abolition of tariffs, expanding sales
networks and the removal of advertising and marketing
restrictions, all policy strategies explicitly pursued by
tobacco transnational companies to increase LMIC con-
sumption rates [56]. McGrady further cautions that ‘the
provisions of trade agreements governing non-tariff bar-
riers to trade will limit effective and comprehensive
tobacco control’ [57].
While using trade treaties to lower tobacco tariffs has
been one strategy adopted by tobacco companies to
increase LMIC consumption, an arguably more critical
strategy has involved using financial market liberaliza-
tion to control domestic tobacco industries worldwide.
Referring to a now famous GATT dispute in 1990 invol-
ving Thailand and the United States, Callard and collea-
gues (2001) speculate that transnational tobacco
companies (TTCs) sought to buy out or enter into a
joint venture with the Thai government’s tobacco
monopoly in order to enhance their economic foothold
in a large market and increase their political influence
with the goal of weakening tobacco control legislation
[58]. GATS mode 3 (commercial presence) facilitates
such investment when countries have committed differ-
ent facets of their domestic tobacco industry to liberali-
zation, although the explosive growth in bilateral
investment treaties likely play an even greater role. Phi-
lip Morris, an American TTC, draws over half of its
cigarette profits from overseas [59]. Less than ten years
ago it was estimated that British American Tobacco
controlled 50% of all Latin American cigarette sales [56].
In the Dominican Republic, Philip Morris became sole
owner of cigarette division Industria de Tabaco León
Jimenes SA and as a report of this buy-out suggests:
Philip Morris could benefit and increase its market
share in the Dominican Republic through more
aggressive marketing now that it has complete con-
trol over the cigarette division. Philip Morris also
could benefit from DR-CAFTA (Central American
Free Trade Agreement) by exporting the products it
manufactures in the Dominican Republic to Central
America [60].
A World Bank study estimated that cigarette produc-
tion in LMICs rose from 40 to 70% in the past few dec-
ades [61], the result primarily of the movement of TTCs
into such countries through domestic company acquisi-
tion and foreign direct investment. In Argentina, for
example, approximately 90% of the tobacco market is
now controlled by two tobacco corporations (Philip
Morris Corporation and British American Tobacco)
neither being domestically owned [50]. In South Africa,
British American Tobacco owns 94% of the tobacco
market [62]. Foreign investment, in turn, is associated
with increased consumption: Gilmore and McKee found
that, amongst former Soviet Union republics, those
countries that received foreign direct investment from
TTCs between 1991 and 2001 saw an increase in
tobacco consumption of 51% compared to a 3% drop in
those that did not [63].
Between 1970 and 2000 the number of hectares
devoted to tobacco growing more than doubled in coun-
tries such as Honduras, Guatemala, Uruguay and Haiti
[64]. In Brazil, the amount of land committed to
tobacco cultivation increased by approximately 60000
hectares [65]. This increase corresponds with the rapid
opening of previously closed markets, the increased
push for trade liberalization and the growth of the
TTCs [66]. While some tobacco farmers and producers
may benefit from this shift to tobacco crop production
(often for export as well as for domestic purposes), this
shift has potential negative implications for domestic
food security and access to nutritional foods with conse-
quent risks to health, especially for the poor. It also
poses direct health risks, especially to children who are
frequently involved in tobacco harvest in low-income
countries, where most of the world’s tobacco is now cul-
tivated [67]. A recent study of child tobacco workers in
Malawi, the fifth leading tobacco producer, estimates
that 78,000 children are exposed to ‘Green Tobacco
Sickness,’ absorbing nicotine at rates equivalent to
smoking up to 50 cigarettes a day [68].
Trade rules and government policy space Tobacco
products generally fall under the WTO’s General Agree-
ment on Tariffs and Trade (GATT), concerned primarily
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with the reduction of import taxes; and the Agreement
on Technical Barriers to Trade, which covers non-tariff
barriers to trade [53]. Tobacco production is also gov-
erned by the AoA with respect to permissible vs. non-
prohibited subsidies to tobacco farmers. Tobacco mar-
keting is covered by both the GATS, with respect to
advertising, and TRIPS, with respect to regulatory restric-
tions that might encroach on cigarette logos as ‘intellec-
tual property rights’. The WTO system makes tacit
reference to health as an interpretative principle [69]; and
there are explicit exceptions that allow countries to avoid
trade rule compliance if it is ‘necessary to protect human,
animal or plant life and health’ (GATT article XX(b);
GATS XIV(b)). Dispute panels, however, have generally
applied a stringent necessity test to these exceptions,
requiring, in regard to tobacco control, that countries
provide sufficient evidence that particular health mea-
sures such as labeling restrictions on cigarette packages
are essential to protect the health of the population, and
that there is no other ‘least trade restrictive’ option
available.
Trade treaties enable tobacco and tobacco products to
cross borders more easily. TTCs, in turn, have sought to
increase their share of the domestic market in LMICs
through strategies that enhance the social image of
smoking [56] such as distributing cigarettes to youth,
public advertising and lobbying governments to ensure
that such strategies are not countered by legislation
[70]. Although trade negotiations have been used by
TTCs as opportunities to ensure that domestic regula-
tions do not seriously imperil such strategies [71], the
Framework Convention on Tobacco Control (FCTC),
negotiated under the WHO system, seeks to strengthen
through a global agreement tobacco control policies to
be pursued by all WHO member states. The FCTC does
show some promise for providing an international legal
basis for health protection over trade and foreign invest-
ment - that is, maintaining or enhancing national policy
space. However, Lo argues that unless guidelines are
specified in the FCTC to restrict the foreign direct
investment of the tobacco industry (which is not pre-
sently the case) [72], the industry can continue to avoid
tariff barriers (finished goods) while still increasing their
presence in domestic markets.
The FCTC contains specific provisions that, assuming
foreign tobacco products are treated the same as domes-
tic ones (the non-discrimination standard of the WTO),
a country’s tobacco control measures should not be sub-
ject to a trade dispute. For example Article 11 of the
FCTC makes the explicit provision that warning labels
on cigarette packages must be “50% or more of the prin-
cipal display areas” with 30% as an absolute minimum
[[73], p. 10]. A government can introduce, without con-
sequence from trade regimes, this provision as long as
the legislation does not discriminate between interna-
tional and domestic cigarette packaging. Tobacco con-
trol measures that exceed the minimum standards set
forth by the FCTC, however, may be challenged (and
are being challenged) under both the WTO system and
bilateral investment treaties.
Further challenges arise under bilateral investment
treaties, which permit private companies to directly sue
national governments for perceived expropriation of
their property and earnings (real or potential). In a
recent case, Philip Morris challenged Uruguay’s decision
to implement larger warning labels on tobacco packages
than the minimum referenced in the FCTC. It used
rules set out in a Swiss-Uruguay investment treaty,
arguing that such warning labels violated its intellectual
property rights by reducing the space in which it could
feature its ‘brand’ name and logos [74]. The difficulty
with disputes involving intellectual property rights
(whether under the TRIPS agreement or bilateral or
regional ‘TRIPS-plus’ treaties) is that the specific trade
rules covering such protection remain ambiguous and
difficult to interpret [75].
Moreover, as Bollyky and Gostin point out, “nearly
every investment and trade agreement negotiated by the
United States eliminates or reduces trading partners’
tobacco tariffs and protects US tobacco companies’
overseas manufacturing and investment” [[76], p.2637].
The USA remains one of the few countries not to ratify
the FCTC, and devotes less than 0.1% of its global
health budget to global tobacco control. The lack of US
support for tough international tobacco control initia-
tives may be why enforceable and profitable trade rules
continue to exert more force than normative and unen-
forceable public health treaties.
Alcohol trade and chronic disease
Concerns are also rising about the impact of numerous
WTO agreements on liberalized trade in alcohol and
consequent alcohol-related health problems. Below we
discuss four pathways linking trade and investment lib-
eralization to alcohol-related chronic diseases: increased
availability, affordability, and marketing of alcohol;
decreased alcohol control policies; domestic health-
related economic effects and non-treaty trade in alcohol.
Increase availability, affordability, and marketing of
alcohol The production, distribution, and marketing of
alcohol are becoming increasingly globalized. Most alco-
holic beverages are largely purchased in the country of
production, although cross-border trade in spirits (pri-
marily those produced in high-income countries) has
become subject to disputes over differential tax regimes
(primarily exercised by LMICs), a point addressed later.
More importantly, and as with tobacco, international
alcohol brands are now being produced industrially in
plants owned, co-owned or licensed by multinational
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corporations [77]. The penetration of transnational alco-
hol corporations in LMIC markets has increased the
availability, affordability, and marketing of alcohol pro-
ducts [78,79] all of which affect consumption rates.
With other factors held constant, a rise in alcohol
prices leads to a reduction in the consumption of alco-
hol and alcohol-related harms [80]. Public health bene-
fits result from higher alcohol prices, even though
demand for alcohol is relatively inelastic to price [81]. A
rise in prices will generally lead to a reduction in con-
sumption that is smaller as a percentage compared to
that of the price increase. Increasing prices tend to have
a greater impact over the long term rather than in the
short term. In addition, young drinkers and frequent
and heavier drinkers (two groups for whom the health
risks of consumption are generally greater) are more
likely to reduce their consumption compared to older
drinkers and infrequent and lighter drinkers [80,82].
Greater diversity of alcohol products made available
through reduced tariffs on imports can increase overall
alcohol consumption as these products can target a vari-
ety of tastes and preferences, although in some cases
consumers may simply shift from domestic to foreign
products [83]. Also, many of the new foreign beverages
contain higher alcohol content compared to domestic
products [78,84].
As alcohol companies ‘thirst for new markets’ [85],
intensive marketing practices are adopted as a means to
increase consumption of alcohol, particularly in LMICs
[83]. The role of advertising is a critical factor in differ-
entiating between ‘globalised’ and other types of alcohol
[79]. Whereas traditional local alcoholic products were
marketed based on availability, quality, and price, a glo-
bal alcohol product is “synonymous with its imagery...
represents a culture of its own” [[77], p. S471]. Alcohol
is being marketed through increasingly sophisticated
avenues, including direct marketing (e.g. podcasting, cell
phones), mainstream media, and via sporting and cul-
tural events. Researchers have demonstrated that adver-
tising is associated with alcohol use by youths, notably
initiation of drinking and hazardous drinking patterns
[80]. ‘False advertising’, such as marketing products as
containing low alcohol when it is consumed as a mixed
drink or the targeting of vulnerable groups have been
employed as a means of counteracting health trends by
consumers towards non alcoholic beverages or drinks
with lower alcohol content [83].
The EU and the USA in current WTO-GATS negotia-
tions are aggressively pursuing unlimited liberalization
commitments in advertising; and “the World Spirits
Alliance has described the Doha Round as offering ‘an
excellent opportunity for the international distilled spir-
its industry to create new opportunities to expand its
exports to world markets,’” identifying “liberalisation of
restrictions on services, including distribution and
advertising’’ as one of its top five priorities for the new
trade round [[86], p.367].
Decrease alcohol control policies In the context of
trade negotiations, alcohol can be treated as a ‘commer-
cial good’ to be freely traded as any other good. The
health-damaging properties of alcohol have been largely
ignored. While there are also some health benefits
related to modest alcohol consumption [87], there are
major health risks which are generally confined to alco-
holism, impaired driving, injuries, and fetal alcohol syn-
drome, although even moderate alcohol use carries
some health risk. Rhem and colleagues estimate that
3.8% of all global deaths and 4.6% of global disability-
adjusted life-years are attributable to alcohol [88].
Domestic regulators must ensure that their alcohol poli-
cies comply with conditions set out in trade treaties,
potentially reducing their capacity to implement appro-
priate policies. Many of the policies that can help reduce
alcohol-related harm (e.g. tariffs, taxes, licensing, label-
ing, regulation of the size of alcoholic beverage contain-
ers, identifying certain brands as ‘noxious’ or ‘injurious’)
are considered to be barriers to trade under several
WTO trade agreements [83].
Reducing the control of state monopolies and enter-
prises is a key element of many trade treaties. Research-
ers have observed an increase in alcohol consumption
and alcohol-related problems following the elimination
of government control of alcohol measures. The Nordic
countries are a case in point. Since the early 20th cen-
tury, Finland, Norway, and Sweden had state monopo-
lies on production and wholesale, import and export,
and off-premise retail monopolies - all with the over-
arching goal of reducing individual and social harm
from alcohol consumption [89]. Following integration
into the European Union (EU) and the European Eco-
nomic Area (EEA), an 1994 agreement for a single Eur-
opean market (Norway is not a member of the EU, but
entered into the EEA), these countries have had to yield
to pressure to undertake trade activities that adopt the
principles of national treatment or non-discrimination.
Alavaikko and Österberg demonstrated that following
Finland’s entry into the European Union in 1995, the
country’s markets opened and the state alcohol mono-
poly company [90], Alko, lost its traditional capacity for
alcohol decision-making policy. Mäkelä and Österberg
observed that alcohol consumption increased 10% in
2004 and levels have remained higher ever since [91].
Another key element of trade treaties is a greater ‘har-
monization’ of taxes and duties on alcoholic beverages
[78]. In particular, national alcohol taxation systems
have been directly affected by the application of the
‘national treatment’ clause. Recently, the EU has
requested the WTO to examine the Philippine’s excise
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tax regime, which includes a higher tax rate on
imported spirits than domestic spirits, which are taxed
at a flat rate [92]. The EU claims that this provides
unfair market competition, whereas the Philippines
defends the law on the grounds that it provides support
to indigenous communities, producing spirits from their
raw materials, like coconut and sugarcane.
Countries have succeeded in maintaining alcohol con-
trol policies when they have been able to demonstrate
that the law was protective to the health of the popula-
tion; exceptions for such a purpose exist in both the
GATT and in the GATS. When health arguments are
not specifically invoked, it is unlikely that a country will
win a dispute. Chile, for example, lost their case on
defending their tax policy on imported spirits before the
WTO [83]. Chile levied a disproportionately high tax
rate on spirits that had alcohol content higher than 40
percent. It did not invoke public health arguments,
instead relying on the argument that its policy was non-
discriminatory, since it applied to all alcohol products,
both domestic and imported. The EU, in this dispute,
countered that most varieties of pisco, the domestically
produced spirit, by law was required to have an alcohol
content below 35 percent; whereas most imported spir-
its had alcohol content of 40 percent or above; thus hav-
ing the effect of providing unfair tax advantage to the
domestic product. The WTO agreed, ruling in favour of
the EU. In its ruling it noted that “members of the
WTO are free to tax distilled alcoholic beverages on the
basis of their alcohol content and price,” which would
appear to allow for a health argument to be made
against high alcohol content imports. But such a policy
would only be permissible “as long as the tax classifica-
tion is not applied so as to protect domestic production
over imports,” meaning that a discriminatory tax on
alcohol content, even if designed for public health pur-
poses, could be found in violation of trade treaty obliga-
tions [93].
There have been countries that have won cases on the
basis of a health defense. One example is France’s Loi
Evin, implemented to restrict alcohol advertising [86].
The European Court which heard this case (which
applied intra-European trade rules) found that while
these prohibitions conflicted with the European Treaty
(Article 59, which stipulates abolishing restrictions on
the provisions of services, including advertising), the
French regulations were deemed appropriate to protect-
ing public health. While European Union law may be
more ‘health friendly’ than WTO trade treaties, Baum-
berg and Anderson argue that policies motivated purely
by health interests may have more flexibility in trade
policy than what is often perceived [94]. They call for
countries implementing alcohol-restricting policies to
pay closer attention to case law in Europe to better
understand how to craft alcohol control policies, and to
avoid narrowing their policy space during ongoing trade
negotiations.
Domestic health-related economic impacts It has been
argued that foreign investments by alcohol corporations
can ‘offset’ the harm caused by increased alcohol con-
sumption in LMICs due to potential economic benefits.
These benefits include employment and income genera-
tion, increased government revenue for governments, a
stronger economy through exports and import substitu-
tion, and the transfer of technology and skills via multi-
national corporations [77,89]. However, while global
markets can increase employment and promote the
transfer of technological advances from high income to
LMICs, global trade tends to benefit rich countries -
particularly a few global corporations [89]. Employment
benefits depend on the local context and the alcohol
product. Trade-related growth in foreign private distri-
butors and retailers over local monopolies, for example,
can drive out alcohol profits from the local economy
[78]. Foreign companies may displace local employment,
since their breweries and production facilities often
require imported technology [77]. Operation of these
facilities tends to require fewer, highly skilled workers.
Companies will often bring in expatriates, reducing
employment opportunities for local populations who
have traditionally worked in the production and trade of
alcohol, such as female heads of households. Local
populations may be marginalized from participation in
this new industry development and unable to reap any
benefits in employment or skill development. Foreign
corporations can also influence the larger political and
economic contexts; as their share of the market
increases, so does their power as actors on the national
and sub-national scales [79].
High taxes on alcohol can be a positive public finance
instrument with public health benefits. However, in
order to collect such revenue, countries need effective
control over the alcohol supply, which many developing
countries do not have [83] and which trade treaty
restrictions on differential taxation by alcohol content
level weaken. Export-oriented policies for alcohol may
not be effective in LMICs, since the global trade necessi-
tates high quality alcohol that can travel long-distances.
Few LMICs are able to produce this type of alcohol or
to compete against well-established international brands,
although tequila and rum are two notable exceptions. In
sum, any potential role for global alcohol trade in
domestic economic development (with implied trickle-
down health benefits) remains ambiguous at best. To
address the growing concerns between the links between
international trade and alcohol, a Framework Conven-
tion on Alcohol Control (FCAC), is being proposed (a
point we return to in the conclusion).
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Trade liberalization, inequity and chronic disease: indirect
pathways
Our framework and this article has focused on specific
(and what we claim now represent progressive effects of
international trade) product pathways. But there are also
generalized features of trade and financial market liber-
alization that have important bearing on chronic disease
risks. These features refer primarily to the inequitable
impacts of global liberalization on socioeconomic and
labour market inequities. Although there is general con-
sensus that extreme poverty globally has fallen in recent
decades [95,96], its attribution to trade liberalization
remains weak [97] and disproportionate to the quadru-
pling in global economic product over the same time
period. Over 3.2 billion people still live below the World
Bank $2/day poverty level, with each unit of global eco-
nomic growth contributing less than half to poverty
reduction today than it did in the 1970s [98]. Trade lib-
eralization is also associated with increased income
inequalities within and between countries [99] along
with geospatial inequalities in developing countries aris-
ing from coastal locations of export-oriented manufac-
turing (including export-processing zones). A possible
reduction in gender income inequalities due to increased
women’s employment has been observed, but with
increased health risks due to unsafe or unhealthy work-
ing conditions [100,101], as well as a growing educa-
tional-based income and job security divide between
‘skilled’ and ‘unskilled’ workers. All forms of stratifica-
tion can lead to social exclusion (both economic and
psychosocial) posing particular health risks for both
infectious and chronic disease.
The trade-related risk for chronic disease is most pro-
nounced with respect to economic insecurities and
labour market changes. The weight of existing evidence
supports the view that trade liberalization increases eco-
nomic insecurity [102]. Workers and producers in the
sectors protected from foreign competition may see rev-
enues decrease or employment disappear when tariffs or
regulatory barriers are removed. As full-time manufac-
turing employment is lost (and not just in high-income,
but also in LMICs, see [103]), there are increases in
‘non-standard’ (insecure, part-time, precarious) forms of
employment [104]. There is a close link between eco-
nomic insecurity and many chronic stress-related dis-
eases such as cardiovascular problems [105]. Insecure
employment in particular is associated with increased
stress leading to a greater risk of both infectious and
chronic disease [106,107].
Trade-related health risks have not gone unnoticed,
both specifically and generally. In the case of tobacco
trade, the FCTC is in part a response to challenges of a
globalized tobacco industry. Its ability to trump trade
treaties invoked by TTCs in their pursuit of larger
markets is still being tested; although the internationali-
zation of tobacco’s singularly negative effects and vilifi-
cation of the tobacco industry may assist in
strengthening the normative, if not narrowly legal, force
of the FCTC. There is no alcohol-equivalent to the
FCTC, although the WHO recently submitted a draft
global strategy to reduce harmful use of alcohol, which
included recommendations and proposals for regulating
availability, marketing and pricing [108]. There is grow-
ing support for the FCAC from diverse actors, including
the Indian Government, the American Public Health
Association, the World Medical Association, and the
WHO Commission on the Social Determinants of
Health [109,110]. A FCAC would help to demonstrate
that alcohol is not an “ordinary commodity” and help to
address global factors influencing its consumption, such
as liberalization of marketing [109]. Even if such a Fra-
mework Convention were negotiated, problems with its
intersection with trade rules (such as those outlined
with the FCTC) would likely remain. The fact that the
health harms arising from alcohol are more ambiguous
may make it more difficult to apply normative pressures
under similar treaty dispute situations.
With respect to the generalized issue of trade and
chronic disease, there is some evidence that increased
social protection programs (e.g. employment insurance,
active labour market programs, welfare cash transfers,
universal health and education access) can buffer some
of the health negative effects of liberalization and global
market integration [102,111]. However, excluding a
handful of rapidly industrializing middle-income coun-
tries, most of the world’s developing countries negatively
affected by the financial crisis lack the fiscal capacity to
expand their social protection programs [112]. Some
high income countries affected by the costs of bank bail-
outs and stimulus spending, or by the recession in the
‘real’ economy of production and consumption, such as
Ireland are making draconian cuts in their existing
social protection spending to qualify for IMF loans.
Conclusion
This article has reviewed extant evidence on the role
that trade and financial liberalization has played in
increasing the global diffusion of risk factors for chronic
disease. The pathways by which trade can affect chronic
disease are multiple. These pathways can be direct
(increased exposure to harmful or potentially harmful
commodities, notably tobacco, obesogenic foods and
alcohol) and indirect (through changes in labour mar-
kets leading to economic and employment insecurity,
associated with increased chronic disease risk). There is
some potential for trade treaties to aid in reducing the
global diffusion of risk factors, such as enforcing an end
to domestic subsidies for agricultural exports harmful to
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health (e.g., sugars, fats, tobacco) or removal of tariffs on
the import of drugs used to treat NCDs. However, as
this article has elaborated, there remains considerable
actual or potential health-harm in trade treaties when
such treaties are driven by liberalization as the policy
end and with only minimal regard to the health
consequences.
This potential has been noticed in the run-up to the
UN Summit on Noncommunicable Diseases taking
place in September, 2011. A meeting of African health
ministers in early April 2011 issued a declaration on
NCDs stating, inter alia, that “although globalization,
trade and urbanization are important in human develop-
ment, they are also major external drivers responsible
for widening health inequities within and between coun-
tries and populations” demanding “the integration of
health in all policies across sectors in order to address
NCD risk factors and determinants [113].” This declara-
tion repeats a theme woven throughout the WHO’s Glo-
bal Status Report on Noncommunicable Diseases 2010,
which noted that “the rapidly growing burden of NCDs
in developing countries is not only accelerated by popu-
lation ageing; it is also driven by the negative effects of
globalization, for example, unfair trade and irresponsible
marketing” [[114], p.33]. WHO Director-General, Mar-
garet Chan, was even more forceful in her comments to
the April, 2011 First Global Ministerial Conference on
Health Lifestyles and Noncommunicable Disease Con-
trol convened in Moscow, regarded as an agenda-setting
event for the September UN Summit:
Today, many of the threats to health that contribute
to noncommunicable diseases come from corpora-
tions that are big, rich and powerful, driven by com-
mercial interests, and far less friendly to health. ...
Today, more than half of the world’s population
lives in an urban setting. Slums need corner food
stores that sell fresh produce, not just packaged junk
with a cheap price and a long shelf-life [115].
While not referencing trade per se, the outcomes
Chan cites are logically and empirically linked to trade
and the globalized food, tobacco and spirits industries.
Yet, notwithstanding the exclusion of the tobacco indus-
try from the Moscow Conference, many of these same
globally trading corporations were present to participate
in the Conference. Press reports of the Conference
quote some of these corporate representatives complain-
ing that companies are “unfairly blamed for consumer’s
choices” or that “the overfed are voluntarily overfed”
[[116], p. 10], reinforcing a concern implicit in the Con-
ference’s emphasis on ‘healthy lifestyles’ that interven-
tion strategies for NCD control could take the easy path
of regulating individual health behaviours rather than
corporate economic or social practices. Such practices
are so far being addressed through calls for voluntary
corporate social responsibility, despite (as one example)
over 30 years of repeated non-compliance with the
voluntary International Code of Marketing of Breastmilk
Substitutes. Any reduction in non-compliance with this
Code was largely a result of activist groups supporting
governments to write Code requirements into their
(enforceable) national legislation [117]. Worryingly, the
declaration issued by the Moscow Conference makes no
reference to globalization, trade or even to EU- and
USA-led initiatives in bilateral or regional trade treaties
to extend intellectual property rights (IPRs), which
could impede access to drugs or diagnostics important
to the treatment of NCDs. Indeed, there is little refer-
ence to IPRs in any of the expressed concerns about
access to medicines in any of the advance commentaries
leading up to the September UN Summit.
These lacunae in discussion of key global determinants
of chronic disease prevention and treatment are surpris-
ing, given the evidence and argument advanced on such
determinants issue in recent years. Whether the direct or
indirect disease implications of global market integration
enters seriously in discussions of global, regional and
bilateral trade treaty negotiations remains a moot ques-
tion. But the same applies to whether trade-related impli-
cations of chronic disease prevention and management
will enter more forcefully into new global debates and
plans to address the rising pandemic of these diseases.
This article, in mapping some of what is known of the
relationships between the two, hopefully will encourage
constructive actions from both sides of the trade/health
table. At minimum, we should expect explicit recognition
of the globalization and trade-related dimension of the
world’s rising burden of chronic disease when nations
meet to discuss plans of action later this year. Ideally, this
should also look for commitments to ensure that trade
negotiators take full account of the health impacts of the
treaties they develop, with sufficient time and public dis-
closure of treaty elements for those in the public health
community (governmental and civil society) to assess,
analyze and respond.
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